Third, the robust neutrophil recruitment activity of aggressive breast cancer cell lines, for example, M4, MDA-MB-231, and BT549, is not further amplified by TGF-β1/TNF-α treatment, even though the latter enhances expression of key EMT markers. This evidence concerns the gene TNF and breast carcinoma.